Endometriosis Is a Cause of Infertility. Does Reactive Oxygen Damage to Gametes and Embryos Play a Key Role in the Pathogenesis of Infertility Caused by Endometriosis?

Approximately, 10–15% of women of reproductive age are affected by endometriosis, which often leads to infertility. Endometriosis often has an inherited component, and several causative predisposing factors are hypothesized to underlie the pathogenesis of endometriosis. One working hypothesis is the theory of retrograde menstruation. According to the theory of retrograde menstruation, components of refluxed blood, including apoptotic endometrial tissue, desquamated menstrual cells, lysed erythrocytes, and released iron, induce inflammation in the peritoneal cavity. This in turn activates macrophage release of reactive oxygen species (ROS), leading to oxidative stress via the respiratory burst. Refluxed blood promotes the Fenton reaction, terminating in the production of hydroxyl radical, the most potently destructive ROS. In this article, we review the papers that demonstrate decreased quantity and quality of oocytes and embryos retrieved from IVF/ICSI patients with endometriosis. We discuss literature data demonstrating that ROS are generated in endometriotic tissues that have physical proximity to gametes and embryos, and demonstrating adverse impacts on oocyte, sperm and embryo microtubule apparatus, chromosomes, and DNA. Data that addresses the notions that endometriosis causes oocyte and fetal aneuploidy and that these events are mediated by ROS species are also discussed. Literature data are also discussed that employ use of anti-oxidant molecules to evaluate the importance of ROS-mediated oxidative damage in the pathogenesis of endometriosis. Studies are discussed that have employed anti-oxidants compounds as therapeutics to improve oocyte and embryo quality in infertile subjects, and improve fertility in patients with endometriosis.

Introduction

Endometriosis is a disease in which endometrial cells migrate outside the uterine cavity and form “implants” that colonize in distal tissues. These include but are not limited to the fallopian tube, the ovary, and peritoneum (1). Endometrial implants are estrogen-dependent for their growth (2). Endometriosis is a frequent finding among infertility patients. Often it takes years before a patient knows she has it. Accurate statistics are not available as to the actual the frequency of the disease. It is commonly accepted that 10 to 15% of reproductive age women are suffering from endometriosis. Twenty-Five to Fifty percent of female patients undergoing fertility treatments are being treated for endometriosis (3).

In infertile patients, an exact staging of endometriosis is very important. The American Society of Reproductive Medicine (ASRM) classification system is used world-wide. The classification is based on laparoscopic findings. Number, location and size of the endometriotic implants are drawn on a figure of the pelvis and degree of adhesions and lesions and the place of the endometriotic tissues are scored. The classification of endometriosis is based on this point score (4). Generally, ASRM I endometriosis is defined by only superficial lesions and possibly a few adhesions, ASRM II endometriosis is defined by some deep lesions in the recto-uterine pouch, ASRM III is defined by the presence of endometriotic tissues on the ovary resulting endometriotic cysts called endometriomas. ASRM IV is defined by large endometriomas with extensive adhesions or deep infiltrating the bowels, the bladder and/or retroperitoneal tissues. Surgical treatments are performed to directly remove endometriotic implants from extrauterine locations. Medical treatments are comprised of long-term GnRH suppression with GnRH agonists to shrink existing endometriotic implants and suppress the growth of new ones. IVF is also used to abrogate infertility caused by endometriosis. For patients with ASRM I and II endometriosis there is a good prognosis for successful infertility treatment using either surgical, or medical treatment and/or assisted reproductive techniques (ART). While there is a 60–70% cumulative clinical pregnancy rate for ASRM I/II patients undergoing ART, the other treatments could also be successful and to date there is no unified view as to what kind of therapy should be recommended for these patients (5). On the other hand, there is now unanimous consensus for stages III and IV that only ART is effective (6). Even so, ART success rates in Stage III/IV patients remain significantly lower than for stage I/II patients (5).

Here we provide an overview of the pathogenesis of endometriosis. We then discuss current and emerging understandings of the pathologic mechanisms by which endometriosis causes infertility. We present that endometriosis induces decreased quantities of oocytes and embryos, decreased embryo quality, and decreased implantation and pregnancy rates in patients with endometriosis. We then discuss evidence that highly reactive free radical species, especially reactive oxygen species (ROS) generated in endometriosis patients damage intracellular structures and genomic material to adversely impact the structural integrity and viability of oocytes, sperm, and embryos, evaluate literature data that implicates oocyte and fetal aneuploidy as contributing factors for infertility caused by endometriosis, and we discuss therapeutic horizons for treatment of endometriosis patients with antioxidant therapies.

Part I: Overview of the Pathogenesis of Endometriosis

Most frequently, endometriotic implants are found in the pelvis. The common sites of endometriotic implants include the surfaces of the ovaries, fallopian tubes, and pelvic peritoneum, all of which have physical proximity to ovarian follicles. The uterosacral ligaments are also common implant sites (alternatively called the “pelvic” sites) (7). Atypical sites for endometriosis include the gastrointestinal tract, urinary tract, soft tissues, and within the thoracic cavity including the pleura and the lungs (8, 9).

Retrograde Menstruation

The most frequent accepted theory that explains the pathogenic process by which these lesions occur is the theory of retrograde menstruation, the theory that the backup of extrinsic menstrual tissues into the fallopian tubes, pelvis, and peritoneum is a driving force in the formation of endometriomal implants. From the study of Halme et al. (10) is well known that 90% of women with patent tubes have peritoneal fluid (PF)/blood in the cul-de-sac during the menstrual period, irrespective of whether they are healthy or suffering from endometriosis. PF is present only in 15% of patients with tubal occlusion. From these data it is evident that the occurrence of retrograde menstruation alone is not sufficient to explain the development of endometriosis. Instead a multifactorial mechanism is likely. This theory helps explain the occurrence of abdominal-pelvic-peritoneal endometriosis, but it does not explain the atypical forms of endometriosis.

Coelomic Metaplasia and Metastatic Spread

In 1969, Ferguson et al. demonstrated Müllerian metaplasia of coelomic epithelia (11). The presence of metaplastic epithelia was also found in the pelvic lymph nodes. This is an evidence that beside the peritoneum other organs may also contain undifferentiated cells. Based on this finding endometrial cell transformation from these cells is theoretically possible. With this theory, not only the pelvic peritoneal forms of endometriomas, but also the atypical endometriomas can be explained.

Altered Immunity

When endometrial tissue relocates to the abdominal cavity—as in the case of retrograde menstruation—both the cellular and humoral immune systems are activated (12). In patients with endometriosis the cellular mediated immune reaction does not recognize the endometrial tissue as “foreign.” This is permissive for endometrial cells to implant in the peritoneum (13, 14). After implantation, macrophage and leukocyte invasion are detected in the surroundings of the implants and in the PF. These cells secrete cytokines and growth factors, including IL1, IL-6, IL8, TNF, VEGF, CCL5, RANTES; and other cytokines (14–16). This complex network of locally produced cytokines stimulates the growth and inflammatory behavior of the ectopic endometrial implants. Proinflammatory cytokines secreted from endometriotic lesions enhance the inflammatory reactions that occur in endometriosis. They promote survival and growth of these lesions and block their demise (17).

Stem Cells

After menstruation, the endometrium regenerates from the lower basal layer. The basal layer contains adult stem cells and a small population of epithelial and stromal stem cells (18). Recently, Cousins and Gargett (19) identified several types of stem/progenitor cells in the basal layer of the endometrium. It is logical to postulate that these types of cells could also reach the abdominal cavity during the menstrual period via retrograde menstruation, to thereby play a key role in the pathogenesis of endometriosis. The notion has also been advanced that non-endometrial stem cells, such as blood-borne bone marrow derived cells, may also reach the abdominal cavity, differentiate into endometrial cells, and implant in the peritoneum and the surfaces of organs in the abdominal cavity (20).

Genetics and Altered Gene Regulation in Endometriosis

Familial inheritance of endometriosis has been widely reported in the literature (21). Saha et al. (22) reported that the incidence of endometriosis in monozygotic twins is double that of dizygotic ones. Based on these data, the best-fitting model revealed a contribution of 47% by additive genetic factors and the remaining 53% attributed to environmental effects. More recently, based on meta-analysis of 17,045 endometriosis cases, Fung and Montgomery (23) suggested that the most common genetic factors contributing to endometriosis risk are located in regulatory DNA sequences that control gene transcription. Genes with altered gene regulatory sequences include LINC00339, VEZT CDC42, and CDKN2A-AS1. CDC and CDK genes encode genes that regulate cell cycle progression. It is logical to hypothesize that dysregulation of their expression may promote endometrial growth. This observation is most consistent with a polygenic/multifactorial etiology, or via causation by several alternate pathways, although alternative mechanisms cannot be excluded.

Part II: How Does Endometriosis Cause Infertility?

Patients With Endometriosis Have Decreased Quality and Quantity of Oocytes and Embryos, Decreased Implantation and Pregnancy Rates, and Increased Rates of Spontaneous Abortion

Patients suffered from endometriosis showed lower ovarian reserved (24). As an indicator of this phenomenon, significantly altered level of serum AMH was reported by Seyhan et al. (25) in endometriosis patients than healthy controls. In contradiction with this, Kucera et al. (26) observed no differences in follicular fluid (FF) AMH levels between women with endometriosis and healthy control women. Several investigators have observed decreases in fertilization rate, yields of high-quality day 3 embryos, rates of blastocyst formation, and rates of implantation and pregnancy in IVF endometriosis patients compared to control subjects, and also in a mouse model of endometriosis embryotoxicity (24, 27–30). A concomitant increase in the rate of spontaneous abortions is also observed (24). Moreover, the severity of alterations depends on the stage of endometriosis: patients with Stage III-IV endometriosis have fewer retrievable oocytes, fewer fertilizable and fertilized oocytes, fewer embryos poorer quality embryos, lower rates of implantation, and fewer fetuses than the group of patients with Stage I-II endometriosis or without endometriosis. The published decrement in the embryological parameters is probably the consequence of oxidative stress processes leading to genetic instability. This will be explained in details in the further sections.

Multiple Factors in the Pathogenesis of Endometriosis-Associated Infertility: An Overview

Mechanical factors

Multiple factors have been implicated as contributing to infertility of patients with endometriosis. Mechanical factors play important roles. Occlusion of the fallopian tubes and peritoneal adhesions impede fertilization and implantation by mechanically blocking the transfer of oocytes, sperm, and embryos through the fallopian tubes. In addition, gamete transfer is inhibited due to impedance of tubal motility due to elevated levels of cytokines (31).

Hormones

Hormonal status is altered significantly in patients with endometriosis. Endometriosis is associated with an increased aromatase enzyme activity in granulosa cells, resulting in elevated follicular estradiol secretion (32). While normal menstrual cycle levels of estradiol promote the healthy development and receptivity of the endometrium, the high estradiol levels of endometriosis patients elicit pathologic changes in the eutopic proliferative and secretory endometrium. Elevated estradiol is also key to the pathogenic process of endometriosis because it drives the growth of extrauterine endometriotic implants.

Endometriosis patients frequently have elevated prostaglandins (33). This causes uterine contractions, which are detrimental to the maintenance of pregnancy. Hyperprolactinemia is another frequent finding, although the cause is not yet clear. Hyperprolactinemia causes corpus luteum dysfunction, which increases rates of spontaneous abortion, the rates of which are significantly higher in patients with endometriosis (34).

HOXA10

The homeobox genes encoding HOXA10/HOXA 10 transcription factors have key roles in embryogenesis, endometrial regeneration, and endometrial receptivity (35). Patients with endometriosis exhibit a failure to increase expression of HOXA10 in the mid luteal phase, at the peak of the implantation window. This is correlated with increased rates of implantation failure.

Endometrial receptivity vs. egg quality

Elevations in estradiol, prostaglandins, HOXA10 expression, and prolactin, as well as progesterone resistance (36) may reduce endometrial receptivity in endometriosis patients, thereby impeding implantation and contributing to their infertility (32, 34, 35). However, while implantation rates are clearly diminished, it is still unknown which impairments in endometrial receptivity are causative factors for infertility in endometriosis patients. In a key study, Simón et al. reported that donor egg recipients with endometriosis receiving eggs from fertile donors had the same rates of implantation and pregnancy as recipients without endometriosis (37). Conversely, donor egg recipients who received eggs donated by patients with endometriosis had significantly reduced implantation rates compared to other patient groups. These data indicate that compromised egg and embryo quality rather than endometrial receptivity plays a principal role in diminished rates of implantation and fecundity in patients with endometriosis.

Immune and inflammatory factors

Immune and inflammatory factors are thought to play key roles in the pathogenesis of infertility in patients with endometriosis, by reducing gamete quality and rates of gamete transport and implantation, and by increasing rates of pregnancy loss. Invasion of macrophages and other leukocytes into the PF and the vicinity of endometriotic implants are thought to play an important role in the pathogenesis of endometriosis infertility by releasing potent, highly reactive free radical species that directly damage sperm, oocytes, and embryos (14). Elevated levels of inflammatory cytokines, growth- and angiogenic factors have toxic effects on sperm, oocytes, embryonal development, gamete transportation, and implantation. Elevated levels of anti-endometrial antibodies are detectable in the blood serum and PF from patients with endometriosis compared to healthy controls. This is correlated with increased frequencies of miscarriages (38). It is reasonable to hypothesize that that these antibodies attack the integrity of the endometrium by compromising sustained implantation and increasing the likelihood of spontaneous abortion. In addition, immune cells generate ROS during this inflammatory process through the respiratory burst NADPH oxidase system (39). Levels of ROS produced by these inflammatory responses in the environments of endometriomal implants are significantly higher in comparison with their healthy counterparts (40). The pathological increase in NADPH oxidase-mediated superoxide (O${}_2^{•-}$) and peroxide production from inflammatory phagocytic cells in the course of this inflammatory reaction acts as source of oxidative stress. Not only the oxidative burst is responsible for oxidative stress. From the refluxed blood, erythrocytes may lose their integrity and iron releases. In the presence of this kind of transition metals other ROS can be produced (29).

Part III: Oxidative Stress and Its Role in Infertility in Patients With Endometriosis

Overview of Oxidative Stress and the Antioxidant Response

Free radicals are ions, atoms or molecules containing a free unpaired electron in the outer electron shell. The free radical state is highly unstable, thus highly reactive in capturing electrons from other molecules. Levels of free radical species in healthy tissues exert important intracellular signal transduction and regulatory functions in folliculogenesis, maturation of oocytes, dissolution of corpora luteal, implantation, and embryo development (40, 41). While free radical species are normal by-products of cellular metabolism, they are produced copiously in the context of inflammation. Due to their chemical instability and reactivity, free radicals in excess do indiscriminate damage to cellular organelles and molecular components, including DNA, RNA, proteins, lipids, carbohydrates, and their building blocks (nucleotides, amino acids, etc.). This results in aberrations in cellular structure and function, and mitotic and meiotic inheritance, and even cell death. Therefore levels of free radical species are closely controlled by endogenous antioxidant molecules that quench their reactivity. The most biologically important types of free radicals in mammalian systems are “reactive oxygen species” (ROS). “Oxidative stress” occurs in cells when there is an unbalanced state of ROS excess compared to available antioxidant activity. This can be caused by excessive production or exposure to ROS, inhibition of antioxidant synthesis, or depletion of antioxidants (42).

Reactive Oxygen Species in vivo

The predominant ROS species are O${}_2^{•-}$, hydrogen peroxide (H₂O₂), and, hydroxyl radical (^•OH) (43). These potent ROS are predominantly the products of incomplete reduction of molecular oxygen in the mitochondrial electron transport system, where electrons leak from the NADH-ubiquinone oxidoreductase to molecular oxygen (44).

Superoxide anion

Approximately, 1–5% of molecular oxygen is converted into O${}_2^{•-}$ by mitochondrial complexes during normal respiration (45). O${}_2^{•-}$ is a highly reactive radical that does significant intracellular damage. O${}_2^{•-}$ is capable of oxidizing cytochrome c in the respiratory chain. It can oxidize polyphenols, tocopherol, and thiol (i.e., cysteine, methionine). Furthermore O${}_2^{•-}$ may be able to inactivate catalase (CAT) a major antioxidant enzyme that is most abundant in peroxisomes.

O${}_2^{•-}$ is able to either reduce or oxidize transition metals (e.g., iron, copper) (46), which function as catalysts for redox reactions that produce reactive oxygen species. Through the reduction of Fe(III) shown in Reaction 1, O${}_2^{•-}$ destroys the Fe-S clusters of proteins, and the reduced iron undergoes additional redox reactions that cause more injuries, as described below (44).

$\begin{array}{cc}\begin{array}{r}\text{F}{\text{e}}^{3+}+{{\text{O}}_2}^{•-}\rightleftarrows \text{F}{\text{e}}^{2+}+{\text{O}}_2\end{array}& (1)\end{array}$

$\begin{array}{cc}\begin{array}{r}\text{F}{\text{e}}^{2+}+2{\text{H}}^{+}+{{\text{O}}_2}^{•-}\rightleftarrows \text{F}{\text{e}}^{3+}+{\text{H}}_2{O}_2\end{array}& (2)\end{array}$

Hydrogen peroxide

As shown in Reaction 2, Fe(II) returns to the oxidized Fe(III) state, in the process catalyzing the production of H₂O₂. Aerobic respiration is also a major source of H₂O₂ in mitochondria. Every system that generates O${}_2^{•-}$ also produces H₂O₂ via a dismutation reaction by the enzyme superoxide dismutase (SOD). Mitochondrial respiration and peroxisomal lipid metabolism are the primary sources of H₂O₂ in eukaryotic cells (47). H₂O₂ is highly reactive in its own right. It forms adducts with various cellular components. It reacts with cysteine and methionine amino acid side chains causing protein damage. However, the greatest damage that is done by H₂O₂ derives from its ability to form hydroxyl radical ^•OH, the most pernicious and reactive of the ROS species.

Hydroxyl radical

The reactivity of O${}_2^{•-}$ and H₂O₂ are significantly lower than that of ^•OH. Intracellular production of ^•OH from H₂O₂ is driven by the Fenton reaction, shown in Reaction 3 (43, 44, 48):

$\begin{array}{cc}\begin{array}{r}\text{F}{\text{e}}^{2+}+{\text{H}}_2{O}_2\rightleftarrows \text{F}{\text{e}}^{3+}{+}^{•}\text{OH}+\text{O}{\text{H}}^{-}\end{array}& (3)\end{array}$

As the most reactive known ROS, ^•OH reacts with nearly all intracellular building blocks and macromolecules (amino acids, nucleic acids, phospholipids, sugars, proteins, RNA, DNA, lipids, polysaccharides). Hence the physiological concentration in cells is about zero. No enzymatic defense against ^•OH is known. The only protection is realized via the strict control of iron metabolism (49).

Antioxidant Defenses

Antioxidants comprise the principal means of intracellular protection from free radical damage (48). The term “antioxidant” is used to describe molecules that directly react with and inactivate ROS species. The term also refers to molecules that function indirectly, either by activating downstream antioxidant protection systems, or by inhibiting pro-oxidant systems that generate ROS. The antioxidants are in two major groups: non-enzymatic systems, and enzymatic systems.

Non-enzymatic-Defense

The glutathione tripeptide molecule (GSH; L-Υ-glutamyl-L-cysteinylglycine) is a key peptide component of intracellular anti-oxidant defense (50). Other classes of non-enzymatic components include vitamins (e.g., ascorbic acid, α-tocopherol), enzymatic cofactors (e.g., Coenzyme Q10), nitrogen compounds (e.g., uric acid), carotenoids (e.g., ß-carotene, lutein), and minerals (e.g., zinc, selenium). There are two forms in cells: reduced (GSH) and oxidized (glutathione disulfide: GSSG). GSH protects cells against oxidative stress by hydrogen or electron donation. The ratio of these two forms is a good indicator of oxidative stress. GSH serves as a cofactor for several detoxification enzyme (e.g., glutathione peroxidase: GPx), assists in the transport of amino acids through the plasma membrane, and is able to regenerate the C- and E-vitamins and direct scavenger of ^•OH and singlet oxygen (42, 47). GSH is a “universal” antioxidant molecule, because it can quench nearly every kind of ROS, including O${}_2^{•-}$, H₂O₂, ^•OH, and peroxidized lipids (51, 52). The balance between GSH and GSSG is maintained by GSH homeostatic enzymatic defense enzymes.

Enzymatic Defense

SOD and catalase

Like GSH, superoxide SOD neutralizes superoxide anion O${}_2^{•-}$. In eukaryotes there are two species of SOD enzyme, copper-zinc SOD and manganese SOD (SOD_CuZn and SOD_Mn). Conversion of O${}_2^{•-}$ to H₂O₂ is performed by the cyclic oxidation of the Cu²⁺ or Mn²⁺ transition metal ion localized in the SOD active site (42, 47). Enzymatic antioxidant defense cannot rely solely on SOD, because that would result in markedly increased tissue damage due to high accumulated levels of intracellular H₂O₂, the substrate for production of ^•OH via the Fenton reaction. Terminal transformation of H₂O₂ to H₂O circumvents H₂O₂ accumulation, and is performed by the CAT enzyme.

Homeostatic regulation of GSH levels

Glutathione peroxidase (GPx), glutathione reductase (GR), glutathione S-transferase (GST), and glucose-6-phosphate dehydrogenase (G6PD) are responsible for recycling of oxidized glutathione (GSSG) back to reduced glutathione (GSH). It is by these means that the GSH molecule neutralize attacks by additional ROS (42, 43).

Reactive Oxygen Species-Mediated Damage to Intracellular Macromolecules

In this section we provide an overview of the types of cellular macromolecules that are damaged by ROS in mammalian cells including endometriotic cells, sperm, oocytes, and embryos, and other cell types.

Point Mutations

Genomic DNA, mitochondrial DNA, and cellular RNA species can be attacked by ^•OH (53, 54). O${}_2^{•-}$ and H₂O₂ do not attack DNA. ^•OH reacts with purine and pyrimidine bases in DNA and RNA (43). ^•OH attacks thymine or deoxyguanosine bases to generate 5-hydroxy-6-hydrothymine or 8-hydroxy-2'-deoxyguanosine (8-OHdG). Measurements of 8-OHdG levels are among the most widely utilized indices of DNA oxidation. Oxidative DNA damage results in mutations that generate dysfunctional protein gene products and altered replication and transcription of crucial genes (44, 53–55).

Oxidative Stress-Induced Lipid Peroxidation

Lipid peroxidation occurs primarily via peroxidation of unsaturated fatty acids, although saturated fatty acids and membrane cholesterol can also undergo peroxidation. The lipid peroxidation process is primarily initiated by ROS (mostly ^•OH) (56). The peroxidized lipid radical reaction product is very unstable and covalently reacts with oxygen to create peroxyl radical. This triggers a chain reaction when the peroxyl radical takes hydrogen from another fatty acid, producing a new lipid radical and a lipid peroxide, and on in a sequence, a process termed propagation. The reaction is only terminated once two radicals react with one another or with an antioxidant molecule (43, 44, 57, 58).

Damage to Proteins

ROS reacts with proteins and disrupts protein folding (44). This results in perturbations in biochemical activities of enzymes, transport proteins, structural proteins, receptors and other proteins such as enzymes that control iron and calcium homeostasis. ^•OH is the predominant ROS species that causes oxidative damage to proteins. It attacks the α hydrogen atom of an amino acid residue to form a carbon-centered radical that reacts with oxygen to generate an alkyl-peroxyl radical and then in two steps an alkoxyl radical. Amino acid side chains of proteins can be also attacked. Cysteine and methionine residues are specifically susceptible to oxidation.

ROS Damage to Oocytes, Sperm, and Embryos, and Prevention by Antioxidants

Oocytes

Aberrations in microtubule integrity, abundance, and alignment at the metaphase plate have been shown to increase susceptibility to errors in meiotic chromosome segregation in animal oocytes, and may do so in human oocytes, and embryos (59–64). ROS damages oocyte spindle microtubules and also blocks formation of new spindle microtubules (65). Several pathways have been found by which ROS promotes damage and disassembly of meiotic spindle microtubules in oocytes (64):

(i) Stability of the spindle is dependent on maintaining the dynamic equilibrium between polymerization (assembly) and depolymerization (disassembly) of tubulin subunits to maintain intact spindle microtubules. ROS inactivate protein kinases that phosphorylate microtubule-associated proteins (MAPs) that maintain this dynamic equilibrium (65).

(ii) ROS impedes mitochondrial respiration, reducing the rate of ATP synthesis via destruction of mtDNA (65, 66). This can be expected to result in GTP depletion. GTP is an essential co-factor for microtubule assembly (67). ROS is thereby expected to impede microtubule assembly.

(iii) A high intracellular ratio of reduced glutathione to oxidized glutathione (GSH/GSSG ratio) is protective of microtubules in their polymerized state by the preventing oxidation of cysteine residues in tubulin subunits. Conversely, a low ratio is permissive for tubulin subunit oxidation, and thus favors microtubule disassembly. Fewer intact microtubules are available to faithfully orchestrate the process of meiotic chromosome segregation in the oocyte (65).

Experimental evidence for oxidative stress-induced chromosome segregation errors in Drosophila melanogaster oocytes was published by Perkins et al. (68). Knock-down of the SOD genes encoding SOD1 and SOD2 induces meiotic chromosome nondisjunction. Zuelke et al. demonstrated that GSH plays an important role in hamster oocyte spindle function. Depletion of GSH with the GSH oxidant diamin disrupted the meiotic spindle apparatus (69). A number of studies have shown chromosome and spindle misalignments and aneuploidy in oocytes of mice exposed to ROS (70–74). For example, germinal vesicle (GV) mouse oocytes were treated with different H₂O₂ concentrations during in vitro maturation displayed concentration dependent increased incidences of misaligned chromosomes, spindle abnormalities, and aneuploidy (75).

A number of studies have shown the ability of antioxidant treatments to protect mouse oocytes from chromosome and spindle misalignments and aneuploidy. Vitamin C, vitamin E, α-lipoic acid and acetyl-carnitine, resveratrol, and N-acetyl cysteine protect oocytes from genomic DNA damage, mitochondrial dysfunction, abnormal spindle morphology, and chromosome misalignments (73–78).

He et al. reported that mouse oocyte mitochondria produce the antioxidant melatonin (79). Treatment of IVM mouse oocytes with melatonin reduces ROS production and inhibits 8-oxodG formation. It increases mitochondrial mtDNA copy number, decreases the fraction of oocytes with spindle aberrations and blastocysts from fertilized oocytes that were treated with melatonin are of higher quality.

Sperm

The coupled pro-oxidant enzyme system xanthine-xanthine oxidase (XXO), generates O${}_2^{•-}$ and H₂O₂ (80). Human spermatozoa treated vitro with XXO show significantly increased DNA fragmentation by TUNEL analyses. Co-incubation with antioxidants significantly reduced rates of DNA fragmentation.

Dietary antioxidant supplementation of men improves their semen parameters. Vitamins A and E reduce sperm DNA fragmentation, pyncogynol improves sperm quality and increases testosterone levels, and alpha lipoic acid improves sperm motility (81–83). These data point to ROS damage as an important determinant of genomic integrity and viability of the male gamete.

Burruel et al. found that XXO increases lipid peroxidation of Rhesus Macaque sperm and it decreases sperm motility (84, 85). They also found adverse outcomes for the embryos from the sperm exposed to ROS damage. MII embryos from macaque oocytes fertilized with these sperm displayed lower rates of embryo development than those that had been fertilized with control sperm, and the embryos ultimately underwent fragmentation and permanent mitotic arrest. In preliminary observations, abnormal mitotic spindles and DNA fragmentation of embryos was also observed, and Burruel et al. suggest that these abnormalities may play roles in causing arrest of the embryos. In a similar study with bull sperm, Barbato et al. also found that XXO increased sperm DNA fragmentation, and it decreased sperm motility and fertilization rates. Blastocysts grown from oocytes fertilized with sperm that had been exposed to XXO displayed decreased blastocyst developmental competence by increasing blastomere DNA fragmentation (86). Treatment with antioxidant Coenzyme Q10 and cofactors mitigated these effects.

Embryos

ROS impedes embryo development and causes embryotoxicity and teratogenesis. Cultured mouse zygotes were treated with H₂O₂ in dose response studies (87, 88). H₂O₂-treated zygotes had elevated levels of ROS, as well as increased oxidative damage, activation of the G2/M checkpoint, decreased cleavage and blastocyst rates, and increased rates of apoptosis. In other studies, phenytoin was used as a reagent to treat mouse embryos because it causes oxidation of DNA, proteins, and lipids, likely due to increased production of ^•OH radicals (89, 90). Cultured gestational day 9.5 mouse embryos treated with phenytoin displayed substantially higher levels of 8-OH-2′-dG DNA modifications than vehicle-treated control embryos and significant developmental damage. Media supplemented with SOD and CAT enzymes reversed 8-OH-2′-dG DNA modifications and prevented morphological anomalies. GSH, vitamin E, and iron chelators also reduce macromolecular embryonal damage and teratogenicity (90).

Part IV: Reactive Oxygen Species and Oxidative Damage in Endometriosis

Proximity of Gametes and Embryos to ROS From Inflammatory Response

ROS are in female oviductal fluid and PF and function as normal signaling modulators of ovulation, embryo development and implantation (91, 92). Endometriomal implants with proximity to the ovary include those that are directly on the surface of the ovary itself, and those that reside in the peritoneum and in the fallopian tubes. These explants have the potential to expose the growing follicle, the oocyte, sperm, and embryos to high levels of ROS that are generated by inflammation.

Endometriomas create physical blockages and can impede normal fluid flow and motility in the oviduct, the peritoneum and the vicinity of the ovary, facilitating the buildup of refluxed blood and its components. These include apoptotic endometrial tissue and desquamated menstrual cells. They trigger an inflammatory response that activates macrophages and neutrophils (93). Elevated serum IL-6 and TNF-α levels indicative of increased inflammatory activity have been observed in patients with endometriosis. Singh et al. found elevation of numerous cytokines within follicles of endometriosis patients compared to those of normal ovulating women, with intrafollicular IL-8, IL-12, and adrenomedullin inversely correlated with rates of oocyte maturation and embryo grade (94). Elevated pro-inflammatory cytokines IL-1β, TNF-α, and IL-6 are indicative of an inflammatory microenvironment for the follicles and gametes and embryos of endometriosis patients (95–98). IL-6 and TNF-α, activate intracellular signal molecules to induce production of O${}_2^{•-}$ and H₂O₂ during the pathogenesis of endometriosis (99) via the respiratory burst NADPH oxidase system (39). Superoxide anion is converted to peroxide by local SOD enzymes (29, 100). Levels of O${}_2^{•-}$ and H₂O₂ produced by these inflammatory responses in the peritoneal, ovarian and oviductal environments of endometriomal implants are significantly higher than those which are generally encountered in their healthy counterparts (40, 93). Elevated ROS levels are also observed in granulosa cells from endometriosis patients (101). Pathological increases in local concentrations of ROS cause oxidative stress (102).

Pernicious Effects of Refluxed Blood and the Balance of Pro-Oxidant and Antioxidant Forces: The Fenton Reaction

In addition to inflammatory components, accumulated refluxed menstrual blood contains numerous lysed erythrocytes. In serum of women with endometriosis, the concentration of iron is significantly increased by 1.98-fold (103), and it is highly likely that the iron concentrations at local implant sites are elevated even further. This along with the elevated level of peroxide is a “perfect storm” for generation of hydroxyl radical, the most reactive and destructive form of ROS. Peroxide is converted to hydroxyl radical ^•OH, which is catalyzed by the excess localized iron via the Fenton reaction. It is by these means that the interplay of these free radical sources is thought to cause ROS damage by ^•OH to the surrounding tissues including the peritoneum, oviduct, ovary, and the follicle, oocyte, sperm and embryos (29, 84, 85, 103–113).

Other Types of Oxidative Damage in Endometriosis

Lipid peroxidation is a sensitive index of oxidative stress induced by ROS. Levels of the peroxidized lipid malondialdehyde (MDA) are significantly elevated in FF of patients suffering from endometriosis compared to control patients with tubal or minimal male infertility (29, 103, 105, 106, 111). Glutathione-S-transferase (GST) enzymes exert antioxidant effects by coupling ROS to glutathione (114). GST concentrations decline significantly in serum and PF as a function of increased severity of endometriosis (115). Indeed, a decrease in total antioxidant capacity is observed in sera of patients with endometriosis (111, 113).

Heat shock proteins (HSPs) play a role of central importance in protecting cells from damage by inflammation, oxidative stress, and other causes (116). Dysregulation of HSPs is implicated in endometriosis. Heat shock chaperone proteins such as Hsp70 carry out key functions in the repair of cellular injury including reversal of protein misfolding that occur due to oxidative damage. Elevated serum HSP70 levels are found in women with endometriosis compared to control women (117). Apoptosis is triggered when ROS-mediated cellular injury is sufficiently severe that it cannot be repaired.

Balance of Pro-Oxidant and Anti-oxidants in Endometriosis

Epithelial cells from deep endometriotic lesions proliferate more rapidly than their normal endometrial counterparts. They too are sources of ROS (112). This includes increased proliferation of endometriotic stromal cells. These proliferating cells produce significantly more O${}_2^{•-}$ and H₂O₂ than their normal epithelial and stromal counterparts (108, 112). Treatment with the potent anti-oxidant N-acetyl cysteine (NAC), a precursor of reduced glutathione (GSH), significantly inhibits proliferation of human endometriotic cells. This may implicate ROS as an autocrine growth factor that promotes the pathogenesis of endometriosis.

Endometriotic stromal and epithelial samples display a significant increase in levels of SOD and GSH. This would be expected to produce an excess of peroxide (112). Singh et al. found 1.9-fold lower specific activity of CAT enzyme in FF of women with endometriosis (29). Singh et al. also found significantly reduced specific activity of CAT (1.9-fold lower), glutathione peroxidase (GPx; 2.7-fold lower), and glutathione reductase (GR; 5-fold lower) in endometriosis tissue samples from patients with endometriosis. Given that CAT, GPx, and GR catalyze the terminal reduction of peroxide to water to prevent accumulation of hydroxyl radicals, this is a potentially ominous finding. Taken together these results suggest another perfect storm, whereby levels of ^•OH are markedly increased in FF, risking increased damage to the follicle and the oocyte, although as discussed above, intracellular hydroxyl radical concentration is not directly measurable due to its extreme chemical reactivity.

Oxidative Stress Caused by the Microenvironment in Endometriosis and Its Effects on the Quality of Oocytes, Sperm, and Embryos

As discussed above, the data from the literature demonstrate lower implantation rates, lower pregnancy rates, and higher miscarriages rates in IVF patients with endometriosis. These patients exhibit lower numbers of retrieved oocytes, lower quality of oocytes, lower number of embryos and quality of embryos, and lower rates of blastocyst formation (24–30). Key aspects of the pathogenesis of endometriosis including diminished fertility have been recapitulated in surgically-induced rodent models of endometriosis (118–120). The mice ovulates the same number of MII oocytes, but a lower percentage is morphologically normal, and the yield of zygotes per dam is diminished. Rats with surgically induced endometriosis have reduced fecundity, develop fewer ovarian follicles, and have morphologically abnormal MII oocytes with increased rates of meiotic chromosome and spindle misalignments compared to sham-operated rats. Day 3 embryos have higher rates of fragmentation and cleavage delayed or arrested cleavage (121). One would predict that semen parameters would also be adversely affected in these models, although Pubmed searches indicate that this study has yet to be performed.

A key hypothesis we are studying here is that in endometriosis, a pro-oxidant microenvironment in the local vicinity of the follicle created by an unbalanced redox state detrimentally impacts the quality of oocytes, sperm, and embryos, hampering their cellular function, jeopardizing their viability, and that this is a fundamental underlying cause of diminished fertility with endometriosis. Since FF and PF comprise key constituents of the local environment to which gametes and preimplantation embryos are exposed, a number of studies have investigated ROS activities and oxidative stress response to FF and PF from IVF patients with endometriosis, and their abilities to damage gametes and embryos.

Mass spectroscopy proteomics of FF from women with endometriosis indicates elevated oxidative stress status (122). Pro-inflammatory cytokines in FF and PF from women with endometriosis are elevated compared to PF and FF of control women (40, 123–126). FF from women with endometriosis has significantly higher levels than FF from control women of advanced oxidation protein products, novel markers of oxidative stress (127). 8-OHdG modifications in DNA are elevated in FF and PF from women with Stage I/II and Stage III/IV endometriosis compared to control patients (54, 105, 128). 8-OHdG elevation may be due to both increased load of ROS and decreased expression of OGG1, the base excision repair gene that excises and repairs single base mutations, which in fact was found in endometriosis patients (105). Studies by Da Broi et al. and by Huang et al. found less antioxidant activity in FF of patients with endometriosis than in control patients with tubal infertility (129, 130). Some controversy remains, however, since a single study by Nakagawa et al. found no elevation of total oxidative stress indices in FF between patients with a unilateral endometrioma and healthy patients (131).

Bovine and mouse IVM MII oocytes were incubated in PF and FF from women with endometriosis vs. from control women to compare their effects on oocyte quality. Oocytes were from animals due to ethical prohibitions against studies that could purposefully damage human oocytes. PF and FF from women with endometriosis caused significantly greater chromosome and spindle misalignments in bovine and mouse MII oocytes than PF and FF from control women (109, 110, 128, 132, 133).

Sperm from healthy men was co-incubated with PF from patients with endometriosis vs. healthy control patients. TUNEL analyses showed significantly more DNA fragmentation of the DNA from sperm incubated with PF from endometriosis patients than from control patients (109). There was no effect on morphology by conventional criteria. In other studies, sperm motility was not impacted by PF from endometriosis patients (134). Fertilization rates of mouse oocytes by mouse sperm co-incubated in PF from endometriosis patients declined significantly from their fertilization rates in PF from control patients (135). Mouse embryos cultured in PF or FF from endometriosis patients show decreased cell number and rates of growth, decreased cleavage and blastulation rates, and increased rates of DNA fragmentation, developmental arrest, embryo toxicity, and apoptosis than mouse embryos cultured in PF or FF from control patients (109, 110, 135–141).

Peritoneal and follicular fluids are complex mixtures with thousands of diverse components. If elevated ROS and/or lower antioxidant activities are responsible for the damage done to gametes and embryos incubated in PF and FF of endometriosis patients, then the addition of antioxidants to PF and FF incubation medium should decrease rates of gamete and embryo damage. Supplementation of PF and FF media from women with endometriosis with N-acetyl cysteine (NAC) or L-carnitine (LC) antioxidants reduced rates of chromosome and spindle abnormalities in mouse and bovine MII oocytes (110, 132). LC also prevented apoptosis of mouse embryos incubated in PF of endometriosis patients (110, 142). The data with NAC indicate that antioxidants can improve egg quality and they support the hypothesis that pro-oxidant activity in FF comprise key components responsible for its detrimental effects on egg quality. As L-carnitine has diverse biological activities, additional studies will be required to determine whether its beneficial effects are attributable to its antioxidant properties. Future studies investigating impacts on oocyte and embryo quality by additional anti-oxidant supplements will be illuminating, as will experiments to determine whether antioxidants can prevent detrimental effects of PF and FF on sperm motility and morphology.

Part V: Could the Altered Microenvironment in Endometriosis Lead to Oocyte and Fetal Aneuploidy?

Aberrations in oocyte spindle integrity and chromosome misalignments at the metaphase plate are predictive of impending aneuploidy (143). Given that PF and FF from women with endometriosis cause chromosome and spindle misalignments in bovine and mouse oocytes, does this mean that endometriosis causes oocyte and fetal aneuploidy?

There are several limitations to the conclusions that can be drawn from the studies with PF and FF. Some studies employed relatively small sample sizes. Experiments analyzed impacts of endometriotic human fluids on healthy oocytes from heterologous animal species. The experimental design is ethical by not exposing human oocytes to treatment that is expected to have an adverse effect. However, it is possible that human oocytes will not be sensitive to the same treatments as animal oocytes. Finally, whereas chromosome and spindle misalignments are likely correlated with impending meiotic aneuploidy, the correlation with aneuploidy is not universal (144).

Rajani et al. found that human IVF-ET patients with endometriosis (n = 56) had comparable numbers of retrieved oocytes, mature MII oocytes, and rates of visualized spindles, vs. invisible spindles, to women with tubal infertility (n = 63) (145). This is significant since the visualization of a spindle is predictive of embryonic developmental competence (146). However, suitable methodology for visualization of spindles was not demonstrated since no pictures of oocyte spindles were presented. In addition, spindle misalignments were not scored, so the question of aneuploidy was not addressed. Fertilization rates, yields per patient of fertilized embryos, and embryo grades were also comparable between the test groups. While there was no significant difference between pregnancy rates, there was a trend toward lower pregnancy rates in patients with endometriosis. These data suggest no significant differences in oocyte or embryo quantity or quality or pregnancy achievement between the test groups. However, we suggest that patients with male infertility would have been a better control group than patients with tubal infertility, given a theoretical potential for pathogenic processes in the ovarian microenvironment for the latter group. In addition, the numbers of patients per test group were small enough that even robust differences may have been missed, according to a chi square power analysis of proportions performed by the authors of this review.

Gianaroli et al. performed PGS analyses of polar bodies biopsied from oocytes from patients undergoing IVF treatment for diverse infertility conditions, including endometriosis (147). Oocytes were retrieved from patients from diverse age groups with different infertility conditions and stimulation protocols. FISH analyses were performed six for chromosomes for which trisomies are most commonly observed –chromosomes 13, 15, 16, 18, 21, and 22. A total of 3,816 oocytes from 544 patients were analyzed. Multivariate regression analyses were performed to evaluate which input variables (i.e., type of infertility, treatment protocol, age group) are most strongly associated with chromosomal abnormalities compared with a control group. Regression coefficients were calculated for the proportion of normal oocytes for each group divided by the number of diagnosed oocytes. A significant relationship was observed between the incidence of endometriosis and the occurrence of errors in any of the six chromosomes (Regression coefficient = −12.223; P < 0.01).

Direct comparison of the fraction of oocytes with one or more aneuploid chromosomes was performed for PB1 from patients in this study with endometriosis (38 cycles) vs. control subjects (58 cycles). The control group was primarily comprised of patients with male factor or idiopathic infertility. 210 of 228 biopsied oocytes were diagnosed in the endometriosis group and 382 of 426 oocytes were diagnosed in the control group. A significantly higher fraction of polar bodies in the endometriosis group exhibited aneuploidy compared to the control group, with 112/210 polar bodies (53%) with a one or more aneuploid chromosomes in the endometriosis group vs. 159/382 polar bodies (42%) in the control group (P = 0.0075, two sided Fisher exact test; L. Gianaroli, personal communication). In control studies with 100 donated oocytes, there was 95% concordance between FISH results between PB1 polar bodies and the oocytes from which they were derived. There was no significant difference in age between the test groups (34.5 years for the endometriosis group and 34.4 years for the control group, P > 0.05). These data indicate with 67% power a higher rate of aneuploidy in oocytes from patients with endometriosis than control patients (chi square test of two proportions). Four-hundred oocytes per test group would be needed to achieve 80% power. Comprehensive chromosomal screening (CCS) of all 24 human chromosomes might have discerned significant differences with the number of oocytes that were available for biopsy.

A very large IVF-ET study by Juneau et al. (148) compared preimplantation embryos by preimplantation genetic testing for aneuploidy (PGT-A). It compared patients with endometriosis (n = 305 patients, 1,880 blastocysts analyzed) to an aggregate population of patients without endometriosis who suffered all other forms of infertility (n = 3,798 patients, 23,054 blastocysts analyzed). Endometriosis patients had fewer oocytes, fewer 2PN embryos, and a nearly significant decline in usable blastocysts (regarded suitable for transfer). Blastocyst PGT-A for all 24 human chromosomes revealed no significant difference in the rates of aneuploidy between all tranched age groups for endometriosis vs. control patients (P > 0.05).

The results of the Juneau et al. study are validated by its large sample size, with the substantial ability to detect differences in aneuploidy rates between test groups, with well over >80% statistical power (Chi square test of two proportions). An actual incidence of oocyte aneuploidy that is higher in the endometriosis patients cannot be ruled out, because attrition of a fraction of aneuploid embryos at earlier growth stages would not have been detected by PGT-A of blastocysts. The control group was a heterogeneous patient population with a variety of infertility disease processes including uterine factor, anovulatory infertility, and tubal factor, each of which could have their own pathogenic process, some perhaps including aneuploidy. PGT-A of blastocysts from women with primarily male factor infertility may have provided a better control. For both Gianaroli et al. and Juneau et al., the severity of endometriosis was not clarified, and without laparoscopic confirmation, the control groups may have included a number of patients with endometriosis.

Overall, the data in the literature demonstrate that endometriosis causes a decline in the quality of oocytes and embryos. Gianaroli et al. provide evidence that endometriosis may cause aneuploidy in the human oocyte, although larger sample sizes are needed to substantiate this. The best data that are available demonstrate that endometriosis is not associated with aneuploidy of embryos that reach the blastocyst stage.

Part VI: Summary and Concluding Remarks

This last section summarizes a working model characterizing modes of action by which ROS produced in endometriosis has adverse impact on the quality of oocytes, sperm and embryos to impede fertility (Figure 1). Endometriotic tissues implanted in the peritoneal space, fallopian tube, and/or on the ovary have proximity to follicles as they grow, and to oocytes, sperm and embryos as they transit through the fallopian tube. These endometriotic tissues are also in direct physical contact with refluxed blood and tissue debris that arrive by the process of retrograde menstruation. This combination triggers potent inflammatory stimuli via macrophage and neutrophil activation and accompanying release of pro-inflammatory cytokines (93, 95–97). This elicits copious production of ROS superoxide anion and peroxide by the inflammatory cells (102, 149). Under these uncontrolled conditions, the concentrations of ROS exceed the capacity of local antioxidant molecules neutralize them (29, 112, 115, 150), resulting in a buildup of ROS O${}_2^{•-}$ and H₂O₂, and also malondialdehyde, at the site of the ovary and in follicular fluid and peritoneal fluid (29, 103, 105, 106, 108, 111, 112). Transitional iron Fe³⁺ released from the stagnated refluxed erythrocytes magnifies the damage by driving production of hydroxyl radical ^•OH^. from peroxide via the Fenton reaction (103). O${}_2^{•-}$ and ^•OH confer damage to DNA, RNA, carbohydrates, proteins, and lipids that comprise cellular organelles in oocytes, sperm, and embryos (43, 48, 109, 110).

FIGURE 1

Figure 1. Schematic working model for the means by which reactive oxygen species in endometriosis promote decline in the quality of oocytes, sperm and embryos to cause infertility. Reactive oxygen species-induced damage also includes damage to membranes, mitochondria, and other organelles (not shown).

Among the most pernicious effects of ROS in women with endometriosis is the extent to which damage to gametes and embryos can be self-perpetuating and even irreversible, by damaging components of the cell that are responsible for information coding and repair of cellular damage. ^•OH. as the most potently reactive ROS species damages DNA by causing ^•OH. causes point mutations, and DNA breaks that cause DNA fragmentation. These damages disrupt the integrity of the genetic code and inheritance for the mitochondrial and nuclear genomes. ^•OH as well O${}_2^{•-}$ and H₂O₂, attack intracellular proteins that maintain the fidelity of DNA replication, and the ability of cells to repair intracellular protein damage. Although there is a robust heat shock response of Hsp70 in endometriosis (117), ROS damages heat shock proteins impeding HSP-mediated re-folding of polypeptides misfolded and otherwise damaged due to oxidative stress. This disruption of DNA replication and repair and HSP protein refolding can trigger mitotic arrest and even apoptosis when injury is severe.

Patients with endometriosis have reduced yields of oocytes. A pathway by which this occurs is suggested in a recent study by Hamdan et al., who found that ROS from human FF of patients with endometriosis damaged mouse oocyte DNA and triggered arrest of meiosis in MI via the DNA damage checkpoint (151). MI resumed upon addition of ROS scavengers to the FF oocyte incubation medium. Overall, irreparable damage to membranous organelles, spindle microtubules, cellular DNA, and the heat shock system itself leads to profound dysfunction of gametes and embryos and even apoptotic cell death, all of which adversely impact fertility (84, 85, 107, 109, 110, 152, 153).

A central role for ROS in the decline of gamete and embryo quality in patients with endometriosis is supported by a series of observations. (i) Eggs, sperm and embryos exhibit poorer quality after exposure in vitro to exogenous ROS, both by morphological and functional criteria. (ii) Gametes and embryos from patients with endometriosis are exposed to an ROS-rich pro-oxidant microenvironment in the fallopian tubes, the ovary, and the follicle. (iii) The quality of sperm, oocytes, and embryos declines significantly upon exposure to PF and FF from patients with endometriosis. (iv) Incubation of gametes and embryos in PF or FF supplemented with antioxidants prevents much of this damage. These data demonstrate that ROS generated in endometriosis is largely responsible for the adverse effect of the endometriotic microenvironment on gamete and embryo quality.

As cited above, a key manifestation of oxidative damage to oocytes in endometriosis is comprised by aberrations in the organization of oocyte meiotic spindles and chromosomes, a key morphologic marker for ROS damage and a widely regarded harbinger of impending oocyte and fetal aneuploidy (62, 84, 85). However while spindle misalignments have been widely reported in endometriosis studies involving mouse and bovine oocytes, spindles in human oocytes from patients with endometriosis have yet to be visualized with sufficient detail to determine whether they have misalignments (154). Paradoxically, work with polar bodies from endometriosis patients indicates increased rates of aneuploidy in patients with endometriosis, with statistically larger sample sizes needed to authenticate this conclusion, while definitive data demonstrate that embryos from endometriosis patients do not (147, 148). Thus, the extent to which endometriosis causes oocyte aneuploidy remains to be answered definitively, and if it does, the extent to which the aneuploidy is caused by ROS in endometriosis will need to be addressed.

Treatment Horizons

Given the in vitro studies showing that antioxidant supplementation of peritoneal and follicular fluids mitigates damage to human sperm, oocytes and embryos, it is logical to predict that in vivo treatments with antioxidants will improve parameters of fertility in endometriosis. A number of antioxidants have been tested. Vitamins C and E (155, 156), N-acetyl cysteine (NAC) (112, 157), resveratrol (58–162), and melatonin (163–166) have variously been shown to reduce the numbers and sizes of endometrotic implants in animal studies. A single study with insufficient statistical power was performed testing the effects of vitamins C and E in humans, and no clinical studies of resveratrol or melatonin effects on endometriotic lesions in women were found in Pubmed searches as of July 2108. However, in a studying employing the human-like SCID mouse model, melatonin induced regression of transplanted human endometriotic lesions (166).

To date the studies with NAC have progressed the most toward therapeutic potential. A combination of NAC with α-lipoic acid (also an antioxidant) and bromelain prevents upregulation of the VCAM1 inflammatory marker, promotes apoptosis of endometriotic but not normal uterine cells, and reduces the size and number of endometriotic lesions in mice (167). A promising clinical trial of women with endometriosis showed decreased diameter and volume, decreased number, and even disappearance of endometriotic lesions after treatment for 3 months with NAC (168). These studies demonstrate a key role for ROS in the growth and/or maintenance of endometriotic lesions. ROS are also essential mediators of angiogenesis, degeneration of extracellular matrix, anti-apoptotic processes, and cellular adhesion processes that participate in the formation and maintenance of endometriotic implants (169). In this way, ROS have at least an indirect impact on the quality of gametes and embryos. As discussed earlier, NAC and other antioxidants prevent chromosome and spindle misalignments and aneuploidy in mouse oocytes and embryos. Future studies will further elucidate the roles of ROS in gametic and embryonic dysfunction and aneuploidy in infertility caused by endometriosis, and therapeutic regimens dedicated to mitigating the impact of ROS on these processes will continue to be developed.

Author Contributions

GM, LB and AT contributed to develop the theory, to the design and implementation of the research and to the writing of the manuscript.

Conflict of Interest Statement

LB is employed by company Pregmama, LLC, Gaithersburg, MD, United States.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abbreviations

8-OHdG, 8-hydroxy-2'-deoxyguanosine; AMH, anti-Müllerian hormone; ART, assisted reproductive technology; ASRM, American Society of Reproductive Medicine; ATP, adenosine triphosphate; CAT, catalase; CCS, comprehensive chromosomal screening; FISH, fluorescence in situ hybridization; FF, follicular fluid; G6PD, glucose-6-phosphate dehydrogenase; GPx, glutathione peroxidase; GR, glutathione reductase; GSH, glutathione; GST, glutathione S-transferase; H₂O₂, hydrogen peroxide; ICSI, intracytoplasmic sperm injection; IL-6, interleukin 6; IVF, in vitro fertilization; LC, L-carnitine; MDA, malondialdehyde; mtDNA, mitochondrial DNA; NAC, N-acetyl cysteine; O${}_2^{•-}$, superoxide anion radical; ^•OH, hydroxyl radical; PF, peritoneal fluid; PGS, preimplantation genetic selection; PGT-A, preimplantation genetic testing for aneuploidy; PN, pronucleus; ROS, reactive oxygen species; SOD, superoxide dismutase; TNF, tumor necrosis factor; XXO, xanthine oxidase.

References

1. Rodgers AK, Falcone T. Treatment strategies for endometriosis. Expert Opin Pharmacother. (2008) 9:243–55. doi: 10.1517/14656566.9.2.243

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. (2013) 10:261–75. doi: 10.1038/nrendo.2013.255

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Kondi-Pafitis A. Pathological aspects of endometriosis. In: Chaudhury K, editor. Endometriosis. London: IntechOpen (2012). p. 3381–93. doi: 10.5772/32433

CrossRef Full Text | Google Scholar

4. American Society for Reproductive Medicine. Revised american society for reproductive medicine classification of endometriosis: 1996. Fertil Steril. (1997) 67:817–21. doi: 10.1016/S0015-0282(97)81391-X

CrossRef Full Text | Google Scholar

5. Senapati S, Barnhart K. Managing endometriosis associated infertility. Clin Obstet Gynecol. (2011) 54:720–6. doi: 10.1097/GRF.0b013e3182353e06

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Pfeifer S, Fritz M, Goldberg J, McClure R, Lobo R, Thomas M, et al. Endometriosis and infertility: a committee opinion. Fertil Steril. (2012) 98: 591–8. doi: 10.1016/j.fertnstert.2012.05.031

CrossRef Full Text | Google Scholar

7. Hyun JL, Ye MP, Byung CJ, Yong BK, Chang SS. Various anatomic locations of surgically proven endometriosis: a single-center experience. Obstet Gynecol Sci. (2015) 58:53–8. doi: 10.5468/ogs.2015.58.1.53

CrossRef Full Text | Google Scholar

8. Sonavane SK, Kantawala KP, Menias CO. Beyond the boundaries-endometriosis: typical and atypical locations. Curr Probl Diagn Radiol. (2011) 40:219–32. doi: 10.1067/j.cpradiol.2011.01.003

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Matalliotakis M, Goulielmos GN, Kalogiannidis I, Koumantakis G, Matalliotakis I, Arici A. Extra pelvic endometriosis: retrospective analysis on 200 cases in two different countries. Eur J Obstet Gynecol Reprod Biol. (2017) 217:34–7. doi: 10.1016/j.ejogrb.2017.08.019

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol. (1984) 64:151–4.

PubMed Abstract | Google Scholar

11. Ferguson BR, Bennington JL, Haber SL. Histochemistry of mucosubstances and histology of mixed müllerian pelvic lymph node glandular inclusions. Evidence for histogenesis by müllerian metaplasia of coelomic epithelium. Obstet Gynecol. (1969) 33:617–25.

PubMed Abstract | Google Scholar

12. Steele RW, Dmowski WP, Marmer DJ. Immunologic aspects of human endometriosis. Am J Reprod Immunol. (1984) 6:33–6. doi: 10.1111/j.1600-0897.1984.tb00106.x

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Dmowski WP, Steele RW, Baker GF. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol. (1981) 15:377–83. doi: 10.1016/0002-9378(81)90598-6

CrossRef Full Text | Google Scholar

14. Macer LM, Taylor HST. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am. (2012) 39:535–49. doi: 10.1016/j.ogc.2012.10.002

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Riccio LDGC, Santulli P, Marcellin L, Ambrao MS, Batteux F, Chapron C. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol. (2018) 50:39–49. doi: 10.1016/j.bpobgyn.2018.01.010

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Nishida M, Nasu K, Narahara H. Role of chemikines in the pathogenesis of endometriosis. Front Biosci. (2011) 3:1196–204. doi: 10.2741/220

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril. (2001) 75:1–10. doi: 10.1016/S0015-0282(00)01630-7

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod. (2004) 70:1738–50. doi: 10.1095/biolreprod.103.024109

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Cousins FL ODF, Gargett CE. Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol. (2018) 50:27–38. doi: 10.1016/j.bpobgyn.2018.01.011

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Du H, Taylor HS. Contribiution of bone marrow-direved stem cells to endometrium and endometriosis. Stem Cells (2007) 25:2082–86. doi: 10.1634/stemcells.2006-0828

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Simpson JL, Elias S, Malinak LR, Buttram VC. Heritable aspects of endometriosis. I. genetic studies. Am J Obstet Gynecol. (1980) 137:327–31. doi: 10.1016/0002-9378(80)90917-5

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Saha R, Pettersson HJ, Svedberg P, Olovsson M, Bergqvist A, Marions L, et al. Heritability of endometriosis. Fertil Steril. (2015) 104:947–52. doi: 10.1016/j.fertnstert.2015.06.035

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Fung JN, Montgomery GW. Genetics of endometriosis: state of the art on genetic risk factors for endometriosis. Best Pract Res Clin Obstet Gynaecol. (2018). 50:61–71. doi: 10.1016/j.bpobgyn.2018

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Carvalho LF, Rossener R, Azeem A, Malvezzi H, Simones Abrao M, Agarwal A. From conception to birth–how endometriosis affects the development of each stage of reproductive life. Minerva Ginecol. (2013) 65:181–98.

Google Scholar

25. Seyhan A, Ata B, Uncu G. The impact of endometriosis and its treatment on ovarian reserve. Semin Reprod Med. (2015) 33:422–8. doi: 10.1055/s-0035-1567820

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Kucera R, Babuska V, Ulcova-Gallova Z, Kulda V, Topolcan O. Follicular fluid levels of anti-Müllerian hormone, insulin-like growth factor 1 and leptin in women with fertility disorders. Syst Biol Reprod Med. (2018) 64:220–3. doi: 10.1080/19396368.2018.1450906

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet. (2010) 27:441–7. doi: 10.1007/s10815-010-9436-1

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Dong X, Liao X, Wang R, Zhang H. The impact of endometriosis on IVF/ICSI outcomes. Int J Clin Exp Pathol. (2013) 6:1911–8.

PubMed Abstract | Google Scholar

29. Singh AK, Chattopadhyay R, Chakravarty B, Chaudhury K. Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF. Reprod Toxicol. (2013) 42:116–24. doi: 10.1016/j.reprotox.2013.08.005

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Fadhlaoui A, de la Joliniére JB, Feki A. Endometriosis and infertility: how and when to treat? Front Surg. (2014) 1:24. doi: 10.3389/fsurg.2014.00024

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Holoch KJ, Lessey BA. Endometriosis and infertility. Clin Obstet Gynecol. (2010) 53:429–38. doi: 10.1097/GRF.0b013e3181db7d71

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Brosens I, Brosens JJ, Benagiano G. The eutopic endometrium in endometriosis: are the changes of clinical significance? Reprod Biomed Online (2012) 24:496–502. doi: 10.1016/j.rbmo.2012.01.022

CrossRef Full Text

33. Rakhila H, Bourcier N, Akoum A, Pouliot M. Abnormal expression of prostaglandins E2 and F2α receptors and transporters in patients with endometriosis. Biomed Res Int. (2015) 2015:808146. doi: 10.1155/2015/808146

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Kohl Schwartz AS, Wölfler MM, Mitter V, Rauchfuss M, Haeberlin F, Eberhard M, et al. Endometriosis, especially mild disease: a risk factor for miscarriages. Fertil Steril. (2017) 108:806–14. doi: 10.1016/j.fertnstert.2017.08.025

CrossRef Full Text | Google Scholar

35. Zanatta A, Rocha AM, Carvalho FM, Pereira RM, Taylor HS, Motta EL, et al. The role of the Hoxa10/HOXA10 gene in the etiology of endometriosis and its related infertility: a review. J Assist Reprod Genet. (2010) 27:701–10. doi: 10.1007/s10815-010-9471-y

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Lessey BA, Ilesanmi AO, Castelbaum AJ, Yuan L, Somkuti SG, Chwalisz K, et al. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin. J Steroid Biochem Mol Biol. (1996) 59:31–9. doi: 10.1016/S0960-0760(96)00103-3

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Simón C, Gutiérrez A, Vidal A, de los Santos MJ, Tarín JJ, Remohí J, et al. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod. (1994) 9:725–9. doi: 10.1093/oxfordjournals.humrep.a138578

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Randall GW, Bush S, Gantt PA. Serum and peritoneal fluid antiendometrial antibodies in assisted reproduction. J Reprod Med. (2009) 54:353–60.

PubMed Abstract | Google Scholar

39. Meitzler JL, Antony S, Wu Y, Juhasz A, Liu H, Jiang G, et al. NADPH oxidases: a perspective on reactive oxygen species production in tumor biology. Antioxid Redox Signal. (2014) 20:2873–89. doi: 10.1089/ars.2013.5603

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. (2005) 3:1–21. doi: 10.1186/1477-7827-3-28

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Agarwal A, Gupta S, Sekhon L, Shah R. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal. (2008) 10:1375–404. doi: 10.1089/ars.2007.1964

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Inertv Aging (2007) 2:219–36.

PubMed Abstract | Google Scholar

43. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Oxford: Oxford University Press (2007).

Google Scholar

44. Li Q, Harvey LM, McNeil B. Oxidative stress in industrial fungi. Crit Rev Biotechnol. (2009) 29:199–213. doi: 10.1080/07388550903004795

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Scandalios JG. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene deffenses. Braz J Med Biol Res. (2005) 38:995–1014. doi: 10.1590/S0100-879X2005000700003

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Carvalho LFP, Samadder AN, Agarwal A, Fernandes LFC, Abrao MS. Oxidative stress biomarkers in patients with endometriosis: systematic review. Arch Gynecol Obstet. (2012) 286:1033–40. doi: 10.1007/s00404-012-2439-7

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Gille G, Sigler K. Oxidative stress and living cells. Folia Microbiol. (1995) 40:131–52. doi: 10.1007/BF02815413

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Carocho M, Ferreira ICFR. A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem Toxicol. (2013) 51:15–25. doi: 10.1016/j.fct.2012.09.021

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Wang W, Ballatori N. Endogenus glutathione conjugates: occurrence and biological functions. Pharmacol Rev. (1998) 50:335–55.

PubMed Abstract | Google Scholar

50. Jones CM, Lawrence A, Wardman P, Burkitt MJ. Kinetics of superoxide scavenging by glutathione: an evaluation of its role in the removal of mitochondrial superoxide. Biochem Soc Trans. (2003) 31:1337–9. doi: 10.1042/bst0311337

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol. (2003) 66:1499–503. doi: 10.1016/S0006-2952(03)00504-5

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Carmel-Harel O, Storz G. Roles of the glutathione- and thioredoxin-dependent reduction system in the Escherichia coli and Saccharomyces cerevisiae responses to oxidative stress. Annu Rev Microbiol. (2000) 54:439–61. doi: 10.1146/annurev.micro.54.1.439

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Shigetomi H, Higashiura Y, Kajihara H, Kobayashi H. A potential link of oxidative stress and cell cycle regulation for development of endometriosis. Gynecol Endocrinol. (2012) 28:897–902. doi: 10.3109/09513590.2012.683071

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Ito F, Yamada Y, Shigemitsu A, Akinishi M, Kaniwa H, Miyake R, et al. Role of oxidative stress in epigenetic modification in endometriosis. Reprod Sci. (2017) 24:1493–502. doi: 10.1177/1933719117704909

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. (2015) 97:55–74. doi: 10.1016/j.ejmech.2015.04.040

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Siddiqui RA, Harvey K, Stillwell W. Anticancer properties of oxidation products of docosahexaenoic acid. Chem Phys Lipids (2008) 153:47–56. doi: 10.1016/j.chemphyslip.2008.02.009

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. (1998) 39:1529–42.

PubMed Abstract | Google Scholar

58. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr. (1993) 57:715–25. doi: 10.1093/ajcn/57.5.715S

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Battaglia DE, Goodwin P, Klein NA, Soules MR. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod. (1996) 11:2217–22. doi: 10.1093/oxfordjournals.humrep.a019080

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Eichenlaub-Ritter U, Shen Y, Tinneberg HR. Manipulation of the oocyte: possible damage to the spindle apparatus. Reprod Biomed Online (2002) 5:117–24. doi: 10.1016/S1472-6483(10)61613-6

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Qiao J, Wang ZB, Feng HL, Miao YL, Wang Q, Yu Y, et al. The root of reduced fertility in aged women and possible therapentic options: current status and future perspects. Mol Aspects Med. (2014) 38:54–85. doi: 10.1016/j.mam.2013.06.001

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Sharma RK, Azeem A, Agarwal A. Spindle and chromosomal alterations in metaphase II oocytes. Reprod Sci. (2013) 20:1293–301. doi: 10.1177/1933719113483018

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Wang WH, Meng L, Hackett RJ, Odenbourg R, Keefe DL. The spindle observation and its relationship with fertilization after intracytoplasmic sperm injection in living human oocytes. Fertil Steril. (2001) 75:348–53. doi: 10.1016/S0015-0282(00)01692-7

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Zhang X, Wu XQ, Lu S, Guo YL, Ma X. Deficit of mitochondria-derived ATP during oxidative stress impairs mouse MII oocyte spindles. Cell Res. (2006) 16:841–50. doi: 10.1038/sj.cr.7310095

PubMed Abstract | CrossRef Full Text | Google Scholar

65. Tarín JJ. Aetiology of age-associated aneuploidy: a mechanism based on the 'free radical theory of ageing'. Mol Hum Reprod. (1995) 1:163–5. doi: 10.1093/molehr/1.4.163

CrossRef Full Text | Google Scholar

66. Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC. Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA. 96:4820–25. doi: 10.1073/pnas.96.9.4820

PubMed Abstract | CrossRef Full Text

67. Berkowitz SA, Wolff J. Intrinsic calcium sensitivity of tubulin polymerization. J Biol Chem. (1981) 10:11216–23.

Google Scholar

68. Perkins AT, Das TM, Panzera LC, Bickel SE. Oxidative stress in oocytes during midprophase induces premature loss of cohesion and chromosome segregation errors. Proc Natl Acad Sci USA. (2016) 113:6823–30. doi: 10.1073/pnas.1612047113

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Zuelke KA, Jones DP, Perreault SD. Glutathione oxidation is associated with altered microtubule function and disrupted fertilization in mature hamster oocytes. Biol Reprod. (1997) 57:1413–9. doi: 10.1095/biolreprod57.6.1413

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Choi WJ, Banerjee J, Falcone T, Bena J, Agarwal A, Sharma RK. Oxidative stress and tumor necrosis factor-alpha-induced alterations in metaphase II mouse oocyte spindle structure. Fertil Steril. (2007) 88:1220–31. doi: 10.1016/j.fertnstert.2007.02.067

PubMed Abstract | CrossRef Full Text | Google Scholar

71. Goud AP, Goud PT, Diamond MP, Gonik B, Abu-Soud HM. Reactive oxygen species and oocyte aging: role of superoxide, hydrogen peroxide, and hypochlorous acid. Free Radic Biol Med. (2008) 44:1295–304. doi: 10.1016/j.freeradbiomed.2007.11.014

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Li YJ, Han Z, Ge L, Zhou CJ, Zhao YF, Wang DH, et al. C-phycocyanin protects against low fertility by inhibiting reactive oxygen species in aging mice. Oncotarget (2016) 7:17393–409. doi: 10.18632/oncotarget.8165

PubMed Abstract | CrossRef Full Text | Google Scholar

73. Liu J, Liu M, Ye X, Liu K, Huang J, Wang L, et al. Delay in oocyte aging in mice by the antioxidant N-acetyl-L-cysteine (NAC). Hum Reprod. (2012) 27:1411–20. doi: 10.1093/humrep/des019

PubMed Abstract | CrossRef Full Text | Google Scholar

74. Navarro PA, Liu L, Ferriani RA, Keefe DL. Arsenite induces aberrations in meiosis that can be prevented by coadministration of N-acetylcysteine in mice. Fertil Steril. (2006) 85:1187–94. doi: 10.1016/j.fertnstert.2005.08.060

PubMed Abstract | CrossRef Full Text | Google Scholar

75. Mihalas BP, De Iuiis GN, Redgrove KA, McLaughlin EA, Nixon B. The lipid peroxidation product 4-hydroxynonenal contributes to oxidative stress-mediated deterioration of the ageing oocyte. Sci Rep. (2017) 7:6247. doi: 10.1038/s41598-017-06372-z

PubMed Abstract | CrossRef Full Text | Google Scholar

76. Liu M, Yin Y, Ye X, Zeng M, Zhao Q, Keefe DL, et al. Resveratrol protects against age-associated infertility in mice. Hum Reprod. (2013) 28:707–17. doi: 10.1093/humrep/des437

PubMed Abstract | CrossRef Full Text | Google Scholar

77. Liang LF, Qi ST, Xian YX, Huang L, Sun XF, Wang WH. Protective effect of antioxidants on the pre-maturation aging of mouse oocytes. Sci Rep. (2017) 7:1434. doi: 10.1038/s41598-017-01609-3

PubMed Abstract | CrossRef Full Text | Google Scholar

78. Silva E, Greene AF, Strauss K, Herrick JR, Schoolcraft WB, Krisher RL. Antioxidant supplementation during in vitro culture improves mitochondrial function and development of embryos from aged female mice. Reprod Fertil Dev. (2015) 27:975–83. doi: 10.1071/RD14474

PubMed Abstract | CrossRef Full Text | Google Scholar

79. He C, Wang J, Zhang Z, Yang M, Li Y, Tian X, et al. Mitochondria synthesize melatonin to ameliorate its function and improve mice oocyte's quality under in vitro conditions. Int J Mol Sci. (2016) 17:939. doi: 10.3390/ijms17060939

PubMed Abstract | CrossRef Full Text | Google Scholar

80. Lopes S, Jurisicova A, Sun JG, Casper RF. Reactive oxygen species: potential cause for DNA fragmentation in human spermatozoa. Hum Reprod. (1998) 13:896–900. doi: 10.1093/humrep/13.4.896

PubMed Abstract | CrossRef Full Text | Google Scholar

81. Greco E, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, Tesarik J. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J Androl. (2005) 26:349–53. doi: 10.2164/jandrol.04146

PubMed Abstract | CrossRef Full Text | Google Scholar

82. Meldrum DR, Gambone JC, Morris MA, Ignarro LJ. A multifaceted approach to maximize erectile function and vascular health. Fertil Steril. (2010) 94:2514–20. doi: 10.1016/j.fertnstert.2010.04.026

PubMed Abstract | CrossRef Full Text | Google Scholar

83. Haghighian HK, Haidari F, Mohammadi-Asl J, Dadfar M. Randomized, triple-blind, placebo-controlled clinical trial examining the effects of alpha-lipoic acid supplement on the spermatogram and seminal oxidative stress in infertile men. Fertil Steril. (2015) 104:318–24. doi: 10.1016/j.fertnstert.2015.05.014

PubMed Abstract | CrossRef Full Text | Google Scholar

84. Burruel V, Klooster KL, Chitwood J, Ross PJ, Meyers SA. Oxidative damage to rhesus macaque spermatozoa results in mitotic arrest and transcript abundance changes in early embryos. Biol Reprod. (2013) 89:72. doi: 10.1095/biolreprod.113.110981

PubMed Abstract | CrossRef Full Text | Google Scholar

85. Burruel V, Klooster K, Barker CM, Pera RR, Meyers S. Abnormal early cleavage events predict early embryo demise: sperm oxidative stress and early abnormal cleavage. Sci Rep. (2014) 4:6598. doi: 10.1038/srep06598

PubMed Abstract | CrossRef Full Text | Google Scholar

86. Barbato V, Talevi R, Braun S, Merolla A, Sudhakaran S, Longobardi S, et al. Supplementation of sperm media with zinc, D-aspartate and co-enzyme Q10 protects bull sperm against exogenous oxidative stress and improves their ability to support embryo development. Zygote (2017) 25:168–75. doi: 10.1017/S0967199416000459

PubMed Abstract | CrossRef Full Text | Google Scholar

87. Qian D, Li Z, Zhang Y, Huang Y, Wu Q, Ru G, et al. Response of mouse zygotes treated with mild hydrogen peroxide as a model to reveal novel mechanisms of oxidative stress-induced injury in early embryos. Oxid Med Cell Longnev. (2016) 2016:1521428. doi: 10.1155/2016/1521428

PubMed Abstract | CrossRef Full Text | Google Scholar

88. Zhang Y, Qian D, Li Z, Huang Y, Wu Q, Ru G, et al. Oxidative stress-induced DNA damage of mouse zygotes triggers G2/M checkpoint and phosphorylates Cdc25 and Cdc2. Cell Stress Chaperon (2016) 21:687–96. doi: 10.1007/s12192-016-0693-5

PubMed Abstract | CrossRef Full Text | Google Scholar

89. Winn LM, Wells PG. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity. Mol Pharmacol. (1995) 48:112–20.

PubMed Abstract | Google Scholar

90. Wells PG, Bhuller Y, Chen CS, Jeng W, Kasapinovic S, Kennedy JC, et al. Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicol Appl Pharmacol. (2005) 207:354–66. doi: 10.1016/j.taap.2005.01.061

PubMed Abstract | CrossRef Full Text | Google Scholar

91. Sharma RK, Agarwal A. Role of reactive oxygen species in gynecologic diseases. Reprod Med Bio (2004) 3:177–99. doi: 10.1111/j.1447-0578.2004.00068.x

PubMed Abstract | CrossRef Full Text | Google Scholar

92. Fujii J, Iuchi Y, Okada F. Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system. Reprod Biol Endocrinol. (2005) 3:43. doi: 10.1186/1477-7827-3-43

PubMed Abstract | CrossRef Full Text | Google Scholar

93. Zeller JM, Hening I, Radwanska E, Dmowski WP. Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am J Reprod Immunol. (1987) 13:78–82. doi: 10.1111/j.1600-0897.1987.tb00097.x

PubMed Abstract | CrossRef Full Text | Google Scholar

94. Singh AK, Dutta M, Chattopadhyay R, Chakravarty B, Chaudhury K. Intrafollicular interleukin-8, interleukin-12, and adrenomedullin are the promising prognostic markers of oocyte and embryo quality in women with endometriosis. J Assist Reprod Genet. (2016) 33:1363–72. doi: 10.1007/s10815-016-0782-5

PubMed Abstract | CrossRef Full Text | Google Scholar

95. Khan KN, Kitajima M, Imamura T, Hiraki K, Fujishita A, Sekine I, et al. Toll-like receptor 4-mediated growth of endometriosis by human heat-shock protein 70. Hum Reprod. (2008) 23:2210–9. doi: 10.1093/humrep/den195

PubMed Abstract | CrossRef Full Text | Google Scholar

96. Martínez S, Garrido N, Coperias JL, Pardo F, Desco J, García-Velasco JA, et al. Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod. (2007) 22:836–42. doi: 10.1093/humrep/del419

PubMed Abstract | CrossRef Full Text | Google Scholar

97. Rier SE, Parsons AK, Becker JL. Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis. Fertil Steril. (1994) 61:294–9. doi: 10.1016/S0015-0282(16)56520-0

PubMed Abstract | CrossRef Full Text | Google Scholar

98. Wu G, Bersinger NA, Mueller MD, von Wolff M. Intrafollicular inflammatory cytokines but not steroid hormone concentrations are increased in naturally matured follicles of women with proven endometriosis. J Assist Reprod Genet. (2017) 34:357–64. doi: 10.1007/s10815-016-0865-3

PubMed Abstract | CrossRef Full Text | Google Scholar

99. Gupta S, Chandra A, Kesavan S, Eapen D, Agarwal A. Oxidative stress and the pathogenesis of endometriosis. In: Garcia-Velasco J, Rizk B, editors. Endometriosis: Current Management and Future Trends. New Delhi: Jaypee Brothers Medical Publishers (2011) pp. 31–9.

Google Scholar

100. Gutteridge JM. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. (1986) 201:291–5. doi: 10.1016/0014-5793(86)80626-3

PubMed Abstract | CrossRef Full Text | Google Scholar

101. Karuputhula NB, Chattopadhyay R, Chakravarty B, Chaudhury K. Oxidative status in granulosa cells of infertile women undergoing IVF. Syst Biol Reprod Med. (2013) 59:91–8. doi: 10.3109/19396368.2012.743197

PubMed Abstract | CrossRef Full Text | Google Scholar

102. Scutiero G, Iannone P, Bernardi G, Bonaccorsi G, Spadaro S, Volta CA, et al. Oxidative stress and endometriosis: a systematic review of the literature. Oxid Med Cell Longev. (2017) 2017:7265238. doi: 10.1155/2017/7265238

PubMed Abstract | CrossRef Full Text | Google Scholar

103. Alizadeh M, Mahjoub S, Esmaelzadeh S, Hajian K, Basirat Z, Ghasemi M. Evaluation of oxidative stress in endometriosis: a case-control study. Caspian J Intern Med. (2015) 6:25–9.

PubMed Abstract | Google Scholar

104. Carvalho LFP, Hui CYY, Agarwal A. Endometriosis and infertility: biomarkers affecting implantation rate. Expert Rev Obstet Gynecol. (2013) 8:467–73. doi: 10.1586/17474108.2013.825456

CrossRef Full Text | Google Scholar

105. Carvalho LFP, Abrao MS, Biscotti C, Sharma R, Nutter B, Falcone T. Oxidative cell injury as a predictor of endometriosis progression. Reprod Sci. (2013) 20:688–98. doi: 10.1177/1933719112466301

PubMed Abstract | CrossRef Full Text | Google Scholar

106. de Lima CB, Cordeiro FB, Camargo M, Zylbersztejn DS, Cedenho AP, Bertolla RP, et al. Follicular fluid lipid peroxidation levels in women with endometriosis during controlled ovarian hyperstimulation. Hum Fertil. (2016) 20:48–54. doi: 10.1080/14647273.2016.1246753

CrossRef Full Text | Google Scholar

107. Gupta S, Goldberg JM, Aziz N, Goldberg E, Krajcir N, Agarwal A. Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril. (2008) 90:247–57. doi: 10.1016/j.fertnstert.2008.02.093

PubMed Abstract | CrossRef Full Text | Google Scholar

108. Leconte M, Nicco C, Ngo C, Chéreau C, Chouzenoux S, Marut W, et al. The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice. Am J Pathol. (2011) 179:880–9. doi: 10.1016/j.ajpath.2011.04.020

PubMed Abstract | CrossRef Full Text | Google Scholar

109. Mansour G, Aziz N, Sharma R, Falcone T, Goldberg J, Agarwal A. The impact of peritoneal fluid from healthy women and from women with endometriosis on sperm DNA and its relationship to the sperm deformity index. Fertil Steril. (2009) 92:61–7. doi: 10.1016/j.fertnstert.2008.05.048

PubMed Abstract | CrossRef Full Text | Google Scholar

110. Mansour G, Sharma RK, Agarwal A, Falcone T. Endometriosis-induced alterations in mouse metaphase II oocyte microtubules and chromosomal alignment: a possible cause of infertility. Fertil Steril. (2010) 94:1894–9. doi: 10.1016/j.fertnstert.2009.09.043

PubMed Abstract | CrossRef Full Text | Google Scholar

111. Nasiri N, Moini A, Eftekhari-Yazdi P, Karimian L, Salman-Yazdi R, Arabipoor A. Oxidative stress statues in serum and follicular fluid of women with endometriosis. Cell J. (2017) 18:582–7. doi: 10.22074/cellj.2016.4724

PubMed Abstract | CrossRef Full Text | Google Scholar

112. Ngo C, Chéreau C, Nicco C, Weill B, Chapron C, Batteux F. Reactive oxygen species controls endometriosis progression. Am J Pathol. (2009) 175:225–34. doi: 10.2353/ajpath.2009.080804

PubMed Abstract | CrossRef Full Text | Google Scholar

113. Rosa e Silva JC, do Amara VF, Mendonça JL, Rosa e Silva AC, Nakao LS, Poli Neto OB, et al. Serum markers of oxidative stress and endometriosis. Clin Exp Obstet Gynecol. (2014) 41:371–4.

Google Scholar

114. Hossain MZ, da Silva JAT, Fujita M. Differential roles of glutathione S-transferase in oxidative stress modulation. In: da Silva JAT, editor. Floriculture, Ornamental and Plant Biotechnology. Advances and Topical Issues. London: Global Science Books Ltd (2006) pp. 108–16.

Google Scholar

115. Mashayekhi S, Salehi Z, Zahiri Z, Mirzajani E, Shahangian S. Correlation between serum and peritoneal fluid glutathione S-transferases T1 concentration with different stages of endometriosis. Middle East Fertil Soc J. (2017) 23:23–26. doi: 10.1016/j.mefs.2017.07.003

CrossRef Full Text | Google Scholar

116. Hartl FU. Molecular chaperones in cellular protein folding. Nature (1996) 381:571–9. doi: 10.1038/381571a0

PubMed Abstract | CrossRef Full Text | Google Scholar

117. Lambrinoudaki IV, Augoulea A, Christodoulakos GE, Economou EV, Kaparos G, Kontoravdis A, et al. Measurable serum markers of oxidative stress response in women with endometriosis. Fertil Steril. (2009) 91:46–50. doi: 10.1016/j.fertnstert.2007.11.021

PubMed Abstract | CrossRef Full Text | Google Scholar

118. Cohen J, Ziyyat A, Naoura I, Chabbert-Buffet N, Aractingi S, Darai E, et al. Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model. J Assist Reprod Genet. (2015) 32:263–70. doi: 10.1007/s10815-014-0390-1

PubMed Abstract | CrossRef Full Text | Google Scholar

119. Han SJ, Hawkins SM, Begum K, Jung SY, Kovanci E, Qin J, et al. A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat Med. (2012) 18:1102–11. doi: 10.1038/nm.2826

PubMed Abstract | CrossRef Full Text | Google Scholar

120. Umezawa M, Saito Y, Tanaka-Hattori N, Takeda K, Ihara T, Sugamata M. Expression profile of extracellular matrix and adhesion molecules in the development of endometriosis in a mouse model. Reprod Sci. (2012) 19:1365–72. doi: 10.1177/1933719112450340

PubMed Abstract | CrossRef Full Text | Google Scholar

121. Stilley JA, Woods-Marshall R, Sutovsky M, Sutovsky P, Sharpe-Timms KL. Reduced fecundity in female rats with surgically induced endometriosis and in their daughters: a potential role for tissue inhibitors of metalloproteinase 1. Biol Reprod. (2009) 80:649–56. doi: 10.1095/biolreprod.108.073411

PubMed Abstract | CrossRef Full Text | Google Scholar

122. Regiani T, Cordeiro FB, da Costa Ldo V, Salgueiro J, Cardozo K, Carvalho VM, et al. Follicular fluid alterations in endometriosis: label-free proteomics by MS(E) as a functional tool for endometriosis. Syst Biol Reprod Med. (2015) 61:263–76. doi: 10.3109/19396368.2015.1037025

PubMed Abstract | CrossRef Full Text | Google Scholar

123. Harada T, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril. (2001) 76:1–10. doi: 10.1016/S0015-0282(01)01816-7

PubMed Abstract | CrossRef Full Text | Google Scholar

124. Gazvani R, Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction (2002) 123:217–26. doi: 10.1530/rep.0.1230217

PubMed Abstract | CrossRef Full Text | Google Scholar

125. Othman Eel-D, Hornung D, Salem HT, Khalifa EA, El-Metwally TH, Al-Hendy A. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol. (2008) 137:240–6. doi: 10.1016/j.ejogrb.2007.05.001

CrossRef Full Text | Google Scholar

126. Ahn SH, Singh V, Tayade C. Biomarkers in endometriosis: challenges and opportunities. Fertil Steril. (2017) 107:523–32. doi: 10.1016/j.fertnstert.2017.01.009

PubMed Abstract | CrossRef Full Text | Google Scholar

127. Song Y, Liu J, Qiu Z, Chen D, Luo C, Liu X, et al. Advanced oxidation protein products from the follicular microenvironment and their role in infertile women with endometriosis. Exp Ther Med. (2018) 15:479–86. doi: 10.3892/etm.2017.5390

PubMed Abstract | CrossRef Full Text | Google Scholar

128. Da Broi MG, Malvezzi H, Paz CC, Ferriani RA, Navarro PA. Follicular fluid from infertile women with mild endometriosis may compromise the meiotic spindles of bovine metaphase II oocytes. Hum Reprod. (2014) 29:315–23. doi: 10.1093/humrep/det378

CrossRef Full Text | Google Scholar

129. Huang B, Li Z, Ai J, Zhu L, Li Y, Jin L, et al. Antioxidant capacity of follicular fluid from patients undergoing in vitro fertilization. Int J Clin Exp Pathol. (2014) 7:2273–82.

PubMed Abstract | Google Scholar

130. Da Broi MG, Jordão AA, Ferriani RA, Navarro PA. Oocyte oxidative DNA damage may be involved in minimal/mild endometriosis-related infertility. Mol Reprod Dev. (2018) 85:128–36. doi: 10.1002/mrd.22943

CrossRef Full Text | Google Scholar

131. Nakagawa K, Hisano M, Sugiyama R, Yamaguchi K. Measurement of oxidative stress in the follicular fluid of infertility patients with an endometrioma. Arch Gynecol Obstet. (2016) 293:197–202. doi: 10.1007/s00404-015-3834-7

PubMed Abstract | CrossRef Full Text | Google Scholar

132. Giorgi VS, Da Broi MG, Paz CC, Ferriani RA, Navarro PA. N-acetyl-cysteine and l-carnitine prevent meiotic oocyte damage induced by follicular fluid from infertile women with mild endometriosis. Reprod Sci. (2016) 23:342–51. doi: 10.1177/1933719115602772

PubMed Abstract | CrossRef Full Text | Google Scholar

133. Jianini BTGM, Giorgi VSI, Da Broi MG, de Paz CCP, Rosa E Silva JC, Ferriani RA, et al. Peritoneal fluid from infertile women with minimal/mild endometriosis compromises the meiotic spindle of metaphase II bovine oocytes: a pilot study. Reprod Sci. (2017) 24:1304–11. doi: 10.1177/1933719116687658

PubMed Abstract | CrossRef Full Text | Google Scholar

134. Sharma RK, Wang Y, Falcone T, Goldberg J, Agarwal A. Effect of peritoneal fluid from endometriosis patients on sperm motion characteristics and acrosome reaction. Int J Fertil Womens Med. (1999) 44:31–7.

PubMed Abstract | Google Scholar

135. Ding GL, Chen XJ, Luo Q, Dong MY, Wang N, Huang HF. Attenuated oocyte fertilization and embryo development associated with altered growth factor/signal transduction induced by endometriotic peritoneal fluid. Fertil Steril. (2010) 93:2538–44. doi: 10.1016/j.fertnstert.2009.11.011

PubMed Abstract | CrossRef Full Text | Google Scholar

136. Abu-Musa A, Takahashi K, Kitao M. Effect of serum from patients with endometriosis on the development of mouse embryos. Gynecol Obstet Invest. (1992) 33:157–60. doi: 10.1159/000294871

PubMed Abstract | CrossRef Full Text | Google Scholar

137. Tzeng CR, Chien LW, Chang AC, Chen AC. Effect of peritoneal fluid and serum from patients with endometriosis on mouse embryo in vitro development. Zhonghua Yi Xue Za Zhi (1994) 54:145–8.

PubMed Abstract | Google Scholar

138. Gomez-Torres MJ, Acien P, Campos A, Velasco I. Embryotoxicity of peritoneal fluid in women with endometriosis. Its relation with cytokines and lymphocyte populations. Hum Reprod. (2002) 17:777–81. doi: 10.1093/humrep/17.3.777

PubMed Abstract | CrossRef Full Text | Google Scholar

139. Esfandiari N, Falcone T, Goldberg JM, Agarwal A, Sharma RK. Effects of peritoneal fluid on preimplantation mouse embryo development and apoptosis in vitro. Reprod Biomed Online (2005) 11:615–9. doi: 10.1016/S1472-6483(10)61170-4

PubMed Abstract | CrossRef Full Text | Google Scholar

140. Shu J, Xing L, Ding G, Luo Q, Liu X, Yan Q, et al. The effect of peritoneal fluid from patients with endometriosis on mitochondrial function and development of early mouse embryos. PLoS ONE (2013) 8:e82334. doi: 10.1371/journal.pone.0082334

PubMed Abstract | CrossRef Full Text | Google Scholar

141. Stilley JA, Birt JA, Sharpe-Timms KL. Cellular and molecular basis for endometriosis-associated infertility. Cell Tissue Res. (2012) 349:849–62. doi: 10.1007/s00441-011-1309-0

PubMed Abstract | CrossRef Full Text | Google Scholar

142. Mansour G, Abdelrazik H, Sharma RK, Radwan E, Falcone T, Agarwal A. L-carnitine supplementation reduces oocyte cytoskeleton damage and embryo apoptosis induced by incubation in peritoneal fluid from patients with endometriosis. Fertil Steril. (2009) 91:2079–86. doi: 10.1016/j.fertnstert.2008.02.097

PubMed Abstract | CrossRef Full Text | Google Scholar

143. Ma W, Baumann C, Viveiros MM. NEDD1 is crucial for meiotic spindle stability and accurate chromosome segregation in mammalian oocytes. Dev Biol. (2010) 339:439–50. doi: 10.1016/j.ydbio.2010.01.009

PubMed Abstract | CrossRef Full Text | Google Scholar

144. Eichenlaub-Ritter U, Vogt E, Cukurcam S, Sun F, Pacchierotti F, Parry J. Exposure of mouse oocytes to bisphenol A causes meiotic arrest but not aneuploidy. Mutat Res. (2008) 651:82–92. doi: 10.1016/j.mrgentox.2007.10.014

CrossRef Full Text | Google Scholar

145. Rajani S, Chattopadhyay R, Goswami SK, Ghosh S, Sharma S, Chakravarty B. Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindle imaging and reactive oxygen species levels in follicular fluid and its relationship with IVF-ET outcome. J Hum Reprod Sci. (2012) 5:187–93. doi: 10.4103/0974-1208.101020

PubMed Abstract | CrossRef Full Text | Google Scholar

146. Moon JH, Hyun CS, Lee SW, Son WY, Yoon SH, Lim JH. Visualization of the metaphase II meiotic spindle in living human oocytes using the Polscope enables the prediction of embryonic developmental competence after ICSI. Hum Reprod. (2003) 18:17–20. doi: 10.1093/humrep/deg165

PubMed Abstract | CrossRef Full Text | Google Scholar

147. Gianaroli L, Magli MC, Cavallini G, Crippa A, Capoti A, Resta S, et al. Predicting aneuploidy in human oocytes: key factors which affect the meiotic process. Hum Reprod. (2010) 25:2374–86. doi: 10.1093/humrep/deq123

PubMed Abstract | CrossRef Full Text | Google Scholar

148. Juneau C, Kraus E, Werner M, Franasiak J, Morin S, Patounakis G, et al. Patients with endometriosis have aneuploidy rates to their age-matched peers in the in vitro fertilization population. Fertil Steril. (2017) 108:284–8. doi: 10.1016/j.fertnstert.2017.05.038

PubMed Abstract | CrossRef Full Text | Google Scholar

149. Hancock JT, Desikan R, Neill SJ. Role of reactive oxygen species in cell signalling pathways. Biochem Soc T. (2001) 29:345–50. doi: 10.1042/bst0290345

PubMed Abstract | CrossRef Full Text | Google Scholar

150. Cooper GM, Hausman RE. The Cell: A Molecual Approach. Washington, DC: ASM Press (2006).

Google Scholar

151. Hamdan M, Jones KT, Cheong Y, Lane SI. The sensitivity of the DNA damage checkpoint prevents oocyte maturation in endometriosis. Sci Rep. (2016) 6:36994. doi: 10.1038/srep36994

PubMed Abstract | CrossRef Full Text | Google Scholar

152. de Assis PM, Castro LS, Siqueira AF, Delgado Jde C, Hamilton TR, Goissis MD, et al. System for evaluation of oxidative stress on in-vitro-produced bovine embryos. Reprod Biomed Online (2015) 31:577–80. doi: 10.1016/j.rbmo.2015.06.014

CrossRef Full Text | Google Scholar

153. Goud PT, Goud AP, Joshi N, Puscheck E, Diamond MP, Abu-Soud HM. Dynamics of nitric oxide, altered follicular microenvironment, and oocyte quality in women with endometriosis. Fertil Steril. (2014) 102:151–9. doi: 10.1016/j.fertnstert.2014.03.053

PubMed Abstract | CrossRef Full Text | Google Scholar

154. Dib LA, Araújo MCPM, Giorgenon RC, Romao GS, Ferriani RA, Navarro PA. Noninvasive imaging of the meiotic spindle of in vivo matured oocytes from infertile women with endometriosis. Rep Sci. (2012) 20:456–62. doi: 10.1177/1933719112459217

PubMed Abstract | CrossRef Full Text | Google Scholar

155. Durak Y, Kokcu A, Kefeli M, Bildircin D, Çelik H, Alper T. Effect of vitamin C on the growth of experimentally induced endometriotic cysts. J Obstet Gynaecol Res. (2013) 39:1253–8. doi: 10.1111/jog.12050

PubMed Abstract | CrossRef Full Text | Google Scholar

156. Erten OU, Ensari TA, Dilbaz B, Cakiroglu H, Altinbas SK, Çaydere M, et al. Vitamin C is effective for the prevention and regression of endometriotic implants in an experimentally induced rat model of endometriosis. Taiwan J Obstet Gynecol. 55:251–7. doi: 10.1016/j.tjog.2015.07.004

PubMed Abstract | CrossRef Full Text

157. Pittaluga E, Costa G, Krasnowska E, Brunelli R, Lundeberg T, Porpora MG, et al. More than antioxidant: N-acetyl-L-cysteine in a murine model of endometriosis. Fertil Steril. (2010) 94:2905–8. doi: 10.1016/j.fertnstert.2010.06.038

PubMed Abstract | CrossRef Full Text | Google Scholar

158. Bayoglu Tekin Y, Guven S, Kirbas A, Kalkan Y, Tumkaya L, Guvendag Guven ES. Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis? Eur J Obstet Gynecol Reprod Biol. (2015) 184:1–6. doi: 10.1016/j.ejogrb.2014.10.041

CrossRef Full Text | Google Scholar

159. Bruner-Tran KL, Osteen KG, Taylor HS, Sokalska A, Haines K, Duleba AJ. Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro. Biol Reprod. (2011) 84:106–12. doi: 10.1095/biolreprod.110.086744

PubMed Abstract | CrossRef Full Text | Google Scholar

160. Yavuz S, Aydin NE, Celik O, Yilmaz E, Ozerol E, Tanbek K. Resveratrol successfully treats experimental endometriosis through modulation of oxidative stress and lipid peroxidation. J Cancer Res Ther. (2014) 10:324–9. doi: 10.4103/0973–1482.136619

PubMed Abstract | CrossRef Full Text | Google Scholar

161. Ozcan Cenksoy P, Oktem M, Erdem O, Karakaya C, Cenksoy C, Erdem A, et al. A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model. Gynecol Endocrinol. (2015) 31:219–24. doi: 10.3109/09513590.2014.976197

CrossRef Full Text | Google Scholar

162. Ergenoglu AM, Yeniel AÖ, Erbaş O, Aktug H, Yildirim N, Ulukuş M, et al. Regression of endometrial implants by resveratrol in an experimentally induced endometriosis model in rats. Reprod Sci. (2013) 20:1230–6. doi: 10.1177/1933719113483014

PubMed Abstract | CrossRef Full Text | Google Scholar

163. Cetinkaya N, Attar R, Yildirim G, Ficicioglu C, Ozkan F, Yilmaz B, et al. The effects of different doses of melatonin treatment on endometrial implants in an oophorectomized rat endometriosis model. Arch Gynecol Obstet. (2015) 291:591–8. doi: 10.1007/s00404-014-3466-3

PubMed Abstract | CrossRef Full Text | Google Scholar

164. Güney M, Oral B, Karahan N, Mungan T. Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril. (2008) 89:934–42. doi: 10.1016/j.fertnstert.2007.04.023

PubMed Abstract | CrossRef Full Text | Google Scholar

165. Kocadal NÇ, Attar R, Yildirim G, Fiçicioglu C, Ozkan F, Yilmaz B, et al. Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. J Turk Ger Gynecol Assoc. (2013) 14:81–6. doi: 10.5152/jtgga.2013.53179

PubMed Abstract | CrossRef Full Text | Google Scholar

166. Yesildaglar N, Yildirim G, Yildirim OK, Attar R, Ozkan F, Akkaya H, et al. The effects of melatonin on endometriotic lesions induced by implanting human endometriotic cells in the first SCID-mouse endometriosis-model developed in Turkey. Clin Exp Obstet Gynecol. (2016) 43:25–30. doi: 10.12891/ceog2035.2016

PubMed Abstract | CrossRef Full Text | Google Scholar

167. Agostinis C, Zorzet S, De Leo R, Zauli G, De Seta F, Bulla R. The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis. Mediators Inflamm. (2015) 2015:918089. doi: 10.1155/2015/918089

PubMed Abstract | CrossRef Full Text | Google Scholar

168. Porpora MG, Brunelli R, Costa G, Imperiale L, Krasnowska EK, Lundeberg T, et al. A promise in the treatment of endometriosis: an observational cohort study on ovarian endometrioma reduction by N-acetylcysteine. Evid Based Complement Alternat Med. (2013) 2013:240702. doi: 10.1155/2013/240702

PubMed Abstract | CrossRef Full Text | Google Scholar

169. Harlev A, Gupta S, Agarwal A. Targeting oxidative stress to treat endometriosis. Expert Opin Ther Targets (2015) 19:1447–64. doi: 10.1517/14728222.2015.1077226